Source-grounded facts extracted from AXT INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
AXT INC reported first quarter ended March 31, 2026 results: revenue $26.9 million, net income $1.6 million net loss, EPS $0.03 per share loss.
“Revenue for the first quarter of 2026 was $26.9 million, compared with $23.0 million for the fourth quarter of 2025 and $19.4 million for the first quarter of 2025.”
AXT INC entered into Underwriting Agreement with Northland Securities, Inc., as representative of the underwriters named therein valued at approximately $550 million (effective 2026-04-21).
“On April 21, 2026, AXT, Inc., a Delaware corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Northland Securities, Inc., as representative of the underwriters named therein (the “Underwriters”) related to the offer and sale of shares of the Company’s common stock (the “Offering”).”
AXT INC reported three months ended March 31, 2026 results: revenue between $28 million and $26 million, net income between $1.6 million and $2.6 million, EPS between $0.03 and $0.05.
“disclosed that its anticipated revenues for the three months ended March 31, 2026, will range between $28 million and $26 million and its anticipated net loss attributed to the Company for the three months ended March 31, 2026, will range between $1.6 million and $2.6 million, or net loss per share (basic and diluted) of between $0.03 and $0.05.”
AXT INC entered into Underwriting Agreement with Northland Securities, Inc., as representative of the underwriters valued at approximately $87 million (effective 2025-12-29).
“On December 29, 2025, AXT, Inc., a Delaware corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Northland Securities, Inc., as representative of the underwriters named therein (the “Underwriters”) related to the offer and sale of shares of the Company’s common stock (the “Offering”).”
AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).
“July 18, 2025. Other than the correction of the date, no other changes have been made to the Initial Report. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . (a) As previously, on July 14, 2025, AXT, Inc. (the “Company”) notified The Nasdaq Stock Market (“Nasdaq”) that as a result of the recent passing of Ms. Christine Russell, the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A) as the Company’s Audit Committee currently consists of only two independent directors, rather than the minimum three independent directors a”
AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).
“January 18, 2025, Nasdaq notified the Company that due to the passing of Ms. Russell, the Company no longer complies with the audit committee requirement under Nasdaq Lising Rule 5605(c)(2)(A). Nasdaq further notified the Company that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance (i) until the earlier of the Company’s next annual meeting of shareholders or July 11, 2026; or, (ii) if the next annual meeting of shareholders is held before January 7, 2026, then the Company must provide evidence of compliance no later t”
AXT INC received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).
“July 14, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Ms. Russell's death, the Company’s Audit Committee has been reduced to two independent directors, and the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of a minimum of three independent directors. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of stockholders or July 11, 2026. The Company intends to regain compliance as soon as possible”
AXT INC reported first quarter, ended March 31, 2024 results: revenue $22.7 million, net income GAAP net loss ... ($2.1) million, EPS ($0.05) per share.
“Revenue for the first quarter of 2024 was $22.7 million, compared with $20.4 million for the fourth quarter of 2023 and $19.4 million for the first quarter of 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.